In this article, we will be taking a look at the $5 billion hedge fund Skye Global’s top 15 stock picks. To skip our detailed analysis of the hedge fund Skye Global, you can go directly to see the $5 Billion Hedge Fund Skye Global’s Top 5 Stock Picks. Rarely does a 28-year-old succeed in raising $75 […]
Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.
Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam, overcoming the initial opposition from the founder of the protein consumables maker. Danaher agreed to buy Abcam in September for $24 per share to expand its portfolio of products and services, but founder Jonathan Milner opposed it saying the offer undervalued the company. Milner, who owns a 6.14% stake, had said he would vote against the acquisition.